AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$JHX

Singh Jesse G sold $10.3M of JHX (indirect holdings)

Singh Jesse G sold 341,457 indirectly-held shares of James Hardie Industries plc (JHX) at an average of $30.21 ($30.08–$30.34, $10.32M total) across 3 trades over 2026-08-21 to 2026-08-24.

Original reporting
SEC EDGAR · Singh Jesse G
Published Aug 25, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

The $10.3M sale reduces insider ownership, possibly weakening confidence among shareholders.

02

Market read

Primary relevance is the insider sell; limited broader market effect.

03

What to watch

No 10b5-1 plan; sale may be tax-driven or personal liquidity need.

Relevance 7/10Novelty 5/10Timing: post-market filing on Aug 25, 2026

Background

Form 4 filings disclose insider transactions; director sales are monitored for potential signals.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Director Jesse G. Singh sold 341,457 shares for $10.3M, reducing his stake to 261,683 shares.

Expected impact

Possible short-term downward pressure; watch for 1-2% dip.

Evidence & confidence

Large $10M sale by a director is material; market may interpret as negative sentiment.

Market effects

Sector

Minimal impact on building materials sector; may slightly affect peer valuations.

Regional

Limited to Australian/UK markets where James Hardie has exposure.

Global

Low global relevance; primarily of interest to investors in JHX.

Counterpoint

What could challenge this read

Insider sell could be routine diversification, not a red flag.

Key entities

  • Company
    James Hardie Industries plc

    Building materials manufacturer listed on NYSE under JHX.

  • Person
    Singh Jesse G.

    Director of James Hardie who executed the share sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JHX insider trading history →

Related articles

AUG 24
$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

investing.com3 min
AUG 21
$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

rte.ie2 min
AUG 21
$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

afr.com1 min
AUG 20
$JHXHighAI 9/10

James Hardie Selling European Fermacell Business for $980 Million to Holcim

James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.

morningstar.com2 min